Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
898
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
-3.01M
-
Total reported value, excl. options
-
$24.5B
-
Value change
-
-$715M
-
Put/Call ratio
-
1.34
-
Number of buys
-
355
-
Number of sells
-
-481
-
Price
-
$193.84
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2024
1,071 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2024.
BIOGEN INC. - COM (BIIB) has 898 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 147M outstanding shares and own 86.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.7M shares), PRIMECAP MANAGEMENT CO/CA/ (16.3M shares), BlackRock, Inc. (15.3M shares), STATE STREET CORP (7.34M shares), JPMORGAN CHASE & CO (5.26M shares), WELLINGTON MANAGEMENT GROUP LLP (5.13M shares), T. Rowe Price Investment Management, Inc. (4.26M shares), GEODE CAPITAL MANAGEMENT, LLC (3.61M shares), NORGES BANK (2.26M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.91M shares).
This table shows the top 898 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.